Leguisan, Mcwelter L.

HRN: 22-30-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
CEFTAZIDIME 1GM (VIAL)
05/23/2025
05/30/2025
IV
1gm
OD
CAP MR
Waiting Final Action 
05/23/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/23/2025
05/28/2025
PO
500mg
OD
CAP MR
Waiting Final Action 
05/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/26/2025
06/02/2025
IV
500
Q8
Amoebiasis
Waiting Final Action 
05/30/2025
METRONIDAZOLE 500MG (TAB)
05/30/2025
06/06/2025
PO
500mg
Q8H
Amoebiasis
Waiting Final Action 
06/02/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/02/2025
06/09/2025
IV
4.5g
Q6h
Empyema, CAP-MR
Waiting Final Action 
06/04/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/04/2025
06/11/2025
PO SWISH AND SWALLOW
100,000 Units
4x A Day
Oral Candidiasis
Waiting Final Action 
06/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/06/2025
06/13/2025
IV
500mg
Q8h
Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: